These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15684637)

  • 1. IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.
    Langenfeld MR; Forst T; Standl E; Strotmann HJ; Lübben G; Pahler S; Kann P; Pfützner A;
    Diabetes Technol Ther; 2004 Dec; 6(6):836-43. PubMed ID: 15684637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.
    Pfützner A; Standl E; Hohberg C; Konrad T; Strotmann HJ; Lübben G; Langenfeld MR; Schulze J; Forst T
    Diabetes Technol Ther; 2005 Jun; 7(3):478-86. PubMed ID: 15929679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.
    Pfützner A; Schöndorf T; Seidel D; Winkler K; Matthaei S; Hamann A; Forst T
    Metabolism; 2006 Jan; 55(1):20-5. PubMed ID: 16324915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.
    Pfützner A; Lorra B; Abdollahnia MR; Kann PH; Mathieu D; Pehnert C; Oligschleger C; Kaiser M; Forst T
    Diabetes Technol Ther; 2006 Jun; 8(3):375-84. PubMed ID: 16800759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
    Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study.
    Musholt PB; Schöndorf T; Pfützner A; Hohberg C; Kleine I; Fuchs W; Hehenwarter S; Dikta G; Kerschgens B; Forst T
    J Diabetes Sci Technol; 2009 Nov; 3(6):1442-50. PubMed ID: 20144400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
    Dworacka M; Abramczyk M; Winiarska H; Kuczynski S; Borowska M; Szczawinska K
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):14-21. PubMed ID: 16425966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
    Forst T; Hohberg C; Fuellert SD; Lübben G; Konrad T; Löbig M; Weber MM; Sachara C; Gottschall V; Pfützner A
    Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
    Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
    Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.
    Putz DM; Goldner WS; Bar RS; Haynes WG; Sivitz WI
    Metabolism; 2004 Nov; 53(11):1454-61. PubMed ID: 15536601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
    Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
    Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study.
    Alssema M; Dekker JM; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ;
    Diabetes Care; 2005 Apr; 28(4):860-5. PubMed ID: 15793186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others].
    Forst T; Pfützner A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S268-73. PubMed ID: 17139585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity.
    Risérus U; Vessby B; Arner P; Zethelius B
    Diabetologia; 2004 Jun; 47(6):1016-9. PubMed ID: 15168020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of leptin to adiponectin can be used as an index of insulin resistance.
    Oda N; Imamura S; Fujita T; Uchida Y; Inagaki K; Kakizawa H; Hayakawa N; Suzuki A; Takeda J; Horikawa Y; Itoh M
    Metabolism; 2008 Feb; 57(2):268-73. PubMed ID: 18191059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.